Spectrum News: Doctor on frontline of COVID-19 pandemic and protests
UC infectious disease expert fights for social justice through medicine
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine is one of the leaders of UC's efforts to battle the COVID-19 pandemic. Spectrum News profiled Fichtenbaum, highlighting his mission of social justice through medicine.
Carl Fichtenbaum, MD, with his guitar. Photo/Lisa Ventre/UC Creative + Brand
Fichtenbaum says he was heavily influenced by his parents, as they fought against social injustice in the 60s. So being an infectious disease doctor seemed to be the right fit.
“That wanting to help people and wanting to make a difference and so I think that’s what got me interested in infectious diseases," he said.
That’s why during one of the most stressful times in his career, he still made sure to make his voice heard this summer after George Floyd’s death.
“I think it’s very important to speak up whenever you hear about any sort of social injustice. Injustice for one is an injustice for all," he said.
Lead photo Joe Fuqua II/UC Creative + Brand
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
German TV highlights UC expert's ancient Maya discoveries
March 2, 2026
The German television show 'Unsolved Case' talks to a University of Cincinnati expert about ballcourts used by the ancient Maya for a program examining how people used spheres as both tools and toys.
UC studies supplement, therapy alternatives to treat depression
March 2, 2026
Media outlets including Cleveland.com and Cleveland's WKYC News highlighted a new University of Cincinnati clinical trial funded by an approximately $3.5 million grant from the National Institutes of Health’s National Center for Complementary and Integrative Health to test two new nonpharmacological treatments for teens and young adults with depression.
'Paradigm-shifting' study confirms effectiveness of long-acting HIV treatment
February 26, 2026
The results of a clinical trial involving the University of Cincinnati, recently published in The New England Journal of Medicine, show people failing HIV treatments with oral medications were able to be treated successfully using injections.